News

Hemostemix's presentation at TERMIS 2025 reflects its commitment to innovation, evidence-based clinical research, and advancing ACP-01 as a new standard of care for patients suffering from peripheral ...
Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in tissue-targeted AAV gene therapy, today announces the ...
Event: H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq Location: Nasdaq World Headquarters, New York, NY Fireside Chat: Tuesday, May 20, 12:30 p.m. EST Webcast: ...
Researchers have developed a novel technology that allows the distribution of components within a single cell to be accurately detected and visualized. Positioning a t-SPESI (tapping-mode scanning ...
Researchers have flagged some "promising" new approaches that could save lives and dramatically improve patient recovery. The ...
Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for ...
University of California, Los Angeles and University of California, San Diego researchers developed an injectable sealant for ...
Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...
Placentas contain a rich amount of nutrients and stem cells, but there’s a difference between eating it at home for wellness ...
A Philadelphia entrepreneur developing eye repair tech stood out among international contenders as it gears up to raise a seed round.
Researchers at Kyushu University in Japan have pinpointed the X-linked mutation behind orange fur in house cats.